当前位置:首页 - 行情中心 - 东宝生物(300239) - 财务分析 - 利润表

东宝生物

(300239)

  

流通市值:28.03亿  总市值:28.96亿
流通股本:5.05亿   总股本:5.22亿

利润表

按照会计年度查询:
报告期2020-03-312019-12-312018-09-302018-06-30
一、营业总收入89,993,866.5491,819,372.27322,296,512.05230,174,896.64
营业收入89,993,866.5491,819,372.27322,296,512.05230,174,896.64
二、营业总成本86,489,663.83460,532,153.82297,832,146.93211,950,879.48
营业成本72,831,984.74398,361,891.69251,780,208.88182,059,902.81
营业税金及附加1,214,901.455,357,590.663,978,898.052,637,237.26
销售费用3,478,374.3419,445,651.1813,801,187.518,969,684.58
管理费用5,162,690.725,995,482.9219,418,164.7115,890,909.93
财务费用885,666.41108,779.811,755,562.621,080,067.79
资产减值损失----1,578,208.721,313,077.11
三、其他经营收益--------
允许价值变动净收益--------
投资净收益-395,468.83-634,285.9864.7257.65
联营、合营企业投资收益-198,188.46-316,163.0864.7257.65
汇兑净收益--------
四、营业利润4,202,698.6637,524,343.5526,859,298.0119,992,558.35
营业外收入4002,628,468.355,954.264,317.24
营业外支出18,706.715,49120,000--
非流动资产处置净损失--------
五、利润总额4,184,391.9540,147,320.926,845,252.2719,996,875.59
所得税675,704.554,540,182.194,060,470.783,216,928.25
未确认的投资损失--------
六、净利润(百万元)7.6133.9822.7816.78
少数股东损益--------
归属于母公司股东的净利润3,508,687.435,607,138.7122,784,781.4916,779,947.34
七、每股收益----0.050.04
基本每股收益0.010.070.050.04
稀释每股收益0.010.070.050.04
TOP↑